Requirement for CB1 but not GABAB receptors in the cholecystokinin mediated inhibition of GABA release from cholecystokinin expressing basket cells

Journal of Physiology

Volumn 589, Issue 4, 2011, Pages 891-902

  Lee, Sang Hun ^a   Soltesz, Ivan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; AGATOXIN TK; BENZYL[3 [[1 (3,4 DICHLOROPHENYL)ETHYL]AMINO] 2 HYDROXYPROPYL]PHOSPHINIC ACID; CALCIUM CHANNEL BLOCKING AGENT; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR ANTAGONIST; CHOLECYSTOKININ; ENDOCANNABINOID; NEUROPEPTIDE; PARVALBUMIN; PRESYNAPTIC RECEPTOR; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BASKET CELL; BRAIN SLICE; CONTROLLED STUDY; DENDRITE; INTERNEURON; NONHUMAN; POSTSYNAPTIC MEMBRANE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SIGNAL TRANSDUCTION; SYNAPSE; ANIMAL; BIOSYNTHESIS; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; HIPPOCAMPAL CA1 REGION; METABOLISM; NERVE CELL INHIBITION; PHYSIOLOGY; SECRETION; SPRAGUE DAWLEY RAT;

ANIMALS; CA1 REGION, HIPPOCAMPAL; CALCIUM CHANNEL BLOCKERS; CHOLECYSTOKININ; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION REGULATION; NEURAL INHIBITION; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTORS, GABA-B;

EID: 79951701420     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2010.198499     Document Type: Article

References (31)

1. Acsady L, Katona I, Martinez-Guijarro FJ, Buzsaki G & Freund TF (2000). Unusual target selectivity of perisomatic inhibitory cells in the hilar region of the rat hippocampus. J Neurosci 20, 6907-6919.
2. A receptor-mediated unitary IPSPs by cannabinoid receptors at synapses between CCK-positive interneurons in rat hippocampus. J Neurophysiol 98, 861-869.
3. Bartos M, Vida I & Jonas P (2007). Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat Rev Neurosci 8, 45-56.
4. Boden PR & Hill RG (1988). Effects of cholecystokinin and pentagastrin on rat hippocampal neurones maintained in vitro. Neuropeptides 12, 95-103.
5. Chhatwal JP, Gutman AR, Maguschak KA, Bowser ME, Yang Y, Davis M et al (2009). Functional interactions between endocannabinoid and CCK neurotransmitter systems may be critical for extinction learning. Neuropsychopharmacology 34, 509-521.
6. Chung L & Moore SD (2009). Cholecystokinin excites interneurons in rat basolateral amygdala. J Neurophysiol 102, 272-284.
7. Cope DW, Maccaferri G, Márton LF, Roberts JD, Cobden PM & Somogyi P (2002). Cholecystokinin-immunopositive basket and Schaffer collateral-associated interneurones target different domains of pyramidal cells in the CA1 area of the rat hippocampus. Neuroscience 109, 63-80.
8. + conductance. J Neurophysiol 74, 990-1000.
9. Daw MI, Tricoire L, Erdelyi F, Szabo G & McBain CJ (2009). Asynchronous transmitter release from cholecystokinin-containing inhibitory interneurons is widespread and target-cell independent. J Neurosci 9, 11112-11122.
10. Deng PY & Lei S (2006). Bidirectional modulation of GABAergic transmission by cholecystokinin in hippocampal dentate gyrus granule cells of juvenile rats. J Physiol 572, 425-442.
11. Deng PY, Xiao Z, Jha A, Ramonet D, Matsui T, Leitges M et al (2010). Cholecystokinin facilitates glutamate release by increasing the number of readily releasable vesicles and releasing probability. J Neurosci 30, 5136-5148.
12. Ellender TJ & Paulsen O (2010). The many tunes of perisomatic targeting interneurons in the hippocampal network. Front Cell Neurosci 4, 26.
13. Földy C, Lee SH, Morgan RJ & Soltesz I (2010). Regulation of fast-spiking basket cell synapses by the chloride channel ClC-2. Nat Neurosci 13, 1047-1049.
14. Földy C, Lee SY, Szabadics J, Neu A & Soltesz I (2007). Cell type-specific gating of perisomatic inhibition by cholecystokinin. Nat Neurosci 10, 1128-1130.
15. Freund TF & Katona I (2007). Perisomatic inhibition. Neuron 56, 33-42.
16. Glickfeld LL & Scanziani M (2006). Distinct timing in the activity of cannabinoid-sensitive and cannabinoid-insensitive basket cells. Nat Neurosci 9, 807-815.
17. Hefft S & Jonas P (2005). Asynchronous GABA release generates long-lasting inhibition at a hippocampal interneuron-principal neuron synapse. Nat Neurosci 8, 1319-1328.
18. Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M & Watanabe M (2009). Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 89, 309-380.
19. Karson MA, Tang AH, Milner TA & Alger BE (2009). Synaptic cross talk between perisomatic-targeting interneuron classes expressing cholecystokinin and parvalbumin in hippocampus. J Neurosci 29, 4140-4154.
20. Karson MA, Whittington KC & Alger BE (2008). Cholecystokinin inhibits endocannabinoid-sensitive hippocampal IPSPs and stimulates others. Neuropharmacology 54, 117-128.
21. Klausberger T, Marton LF, O'Neill J, Huck JH, Dalezios Y, Fuentealba P et al (2005). Complementary roles of cholecystokinin- and parvalbumin-expressing GABAergic neurons in hippocampal network oscillations. J Neurosci 25, 9782-9793.
22. Kurrikoff K, Inno J, Matsui T & Vasar E (2008). Stress-induced analgesia in mice: evidence for interaction between endocannabinoids and cholecystokinin. Eur J Neurosci 27, 2147-2155.
23. Lee SH, Földy C & Soltesz I (2010). Distinct endocannabinoid control of GABA release at perisomatic and dendritic synapses in the hippocampus. J Neurosci 30, 7993-8000.
24. Lee SY & Soltesz I (2011). Cholecystokinin: A multi-functional molecular switch of neuronal circuits. Dev Neurobiol 71, 83-91.
25. + conductance in hippocampal interneurons. J Neurosci 17, 4994-5003.
26. Neu A, Földy C & Soltesz I (2007). Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus. J Physiol 578, 233-247.
27. Noble F & Roques BP (2006). Cholecystokinin peptides in brain function. In Handbook of Neurochemistry and Molecular Neurobiology, 3rd edn, ed. Lajtha A, pp. 545-571. Springer Science + Business Media, New York
28. Pawelzik H, Hughes DI & Thomson AM (2002). Physiological and morphological diversity of immunocytochemically defined parvalbumin- and cholecystokinin-positive interneurones in CA1 of the adult rat hippocampus. J Comp Neurol 443, 346-367.
29. Vida I, Halasy K, Szinyei C, Somogyi P & Buhl EH (1998). Unitary IPSPs evoked by interneurons at the stratum radiatum-stratum lacunosum-moleculare border in the CA1 area of the rat hippocampus in vitro. J Physiol 506, 755-773.
30. Wilson RI, Kunos G & Nicoll RA (2001). Presynaptic specificity of endocannabinoid signaling in the hippocampus. Neuron 31, 453-462.
31. Zaitsev AV, Povysheva NV, Lewis DA & Krimer LS (2007). P/Q-type, but not N-type, calcium channels mediate GABA release from fast-spiking interneurons to pyramidal cells in rat prefrontal cortex. J Neurophysiol 97, 3567-3573.